Abstract |
Chronic hepatitis B virus (HBV) infection is the result of an inadequate antiviral immune response to the virus. In this study, we aimed to investigate whether the soluble CD40 ligand-activated B (CD40-B) cells could present antigen and induce specific cytotoxic T lymphocytes (CTLs) in patients with chronic HBV infection. We observed that after activated by sCD40L, the expression of CD80, CD86, major histocompatibility complex (MHC) I and II molecules on the CD40-B cells was significantly increased. Cytometry and fluorescence microscopy showed that more than 41.34% CD40-B cells were loaded by the HBcAg peptide. Furthermore, after been activated and HBcAg18-27 antigen peptide pulsed, B cells obtained from patients with chronic HBV infection could induce HBcAg18-27 specific CTLs in vitro. Taken together, our results show that B cells from patients with chronic HBV infection can be activated by sCD40L and may function as antigen presenting cells and induce HBV-specific CTLs.
|
Authors | Yong Liu, Rui Huang, Yali Xiong, Qi Zhao, Guangmei Chen, Juan Xia, Chao Wu |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 450
Issue 1
Pg. 61-6
(Jul 18 2014)
ISSN: 1090-2104 [Electronic] United States |
PMID | 24866241
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- CD40 Antigens
- Hepatitis B Core Antigens
|
Topics |
- Antigen-Presenting Cells
(immunology, virology)
- B-Lymphocytes
(immunology, virology)
- CD40 Antigens
(immunology)
- Cells, Cultured
- Hepatitis B Core Antigens
(immunology)
- Hepatitis B virus
(immunology)
- Hepatitis B, Chronic
(immunology, virology)
- Humans
- Solubility
- T-Lymphocytes, Cytotoxic
(immunology, virology)
|